Market Closed -
BOERSE MUENCHEN
20:43:40 28/06/2024 BST
|
5-day change
|
1st Jan Change
|
38.8
EUR
|
+1.57%
|
|
-0.51%
|
0.00%
|
Fiscal Period: Dezember |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,438
|
-
|
-
|
Enterprise Value (EV)
1 |
8,981
|
8,830
|
8,629
|
P/E ratio
|
30.2
x
|
28.7
x
|
26.4
x
|
Yield
|
1.18%
|
1.25%
|
1.32%
|
Capitalization / Revenue
|
3
x
|
2.85
x
|
2.7
x
|
EV / Revenue
|
3.2
x
|
2.99
x
|
2.76
x
|
EV / EBITDA
|
14.3
x
|
12.7
x
|
11.3
x
|
EV / FCF
|
36.2
x
|
30.5
x
|
25.6
x
|
FCF Yield
|
2.76%
|
3.28%
|
3.9%
|
Price to Book
|
10.3
x
|
8.33
x
|
6.89
x
|
Nbr of stocks (in thousands)
|
200,004
|
-
|
-
|
Reference price
2 |
42.19
|
42.19
|
42.19
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: Dezember |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,678
|
2,810
|
2,956
|
3,125
|
EBITDA
1 |
-
|
628.6
|
696.2
|
760.4
|
EBIT
1 |
-
|
441.2
|
477.3
|
511
|
Operating Margin
|
-
|
15.7%
|
16.14%
|
16.35%
|
Earnings before Tax (EBT)
1 |
-
|
374.7
|
415
|
437.5
|
Net income
1 |
260
|
280.9
|
294.3
|
318.3
|
Net margin
|
9.71%
|
9.99%
|
9.95%
|
10.18%
|
EPS
2 |
-
|
1.399
|
1.471
|
1.596
|
Free Cash Flow
1 |
-
|
247.9
|
289.5
|
336.9
|
FCF margin
|
-
|
8.82%
|
9.79%
|
10.78%
|
FCF Conversion (EBITDA)
|
-
|
39.44%
|
41.58%
|
44.3%
|
FCF Conversion (Net income)
|
-
|
88.28%
|
98.38%
|
105.84%
|
Dividend per Share
2 |
-
|
0.4992
|
0.5283
|
0.5581
|
Announcement Date
|
29/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
670
|
719.6
|
702.7
|
710.1
|
697
|
757.6
|
EBITDA
1 |
131
|
170.1
|
158.1
|
163.8
|
143.6
|
191.8
|
EBIT
1 |
90
|
122.9
|
110.6
|
114.4
|
93.94
|
136.9
|
Operating Margin
|
13.43%
|
17.07%
|
15.74%
|
16.11%
|
13.48%
|
18.08%
|
Earnings before Tax (EBT)
1 |
73
|
105
|
94.33
|
102.3
|
78.5
|
125.5
|
Net income
1 |
56
|
77.98
|
71.4
|
76.44
|
54
|
89
|
Net margin
|
8.36%
|
10.84%
|
10.16%
|
10.76%
|
7.75%
|
11.75%
|
EPS
2 |
0.2800
|
0.3834
|
0.3583
|
0.3755
|
0.2749
|
0.4388
|
Dividend per Share
2 |
0.1300
|
0.1250
|
0.1250
|
0.1250
|
0.1275
|
0.1275
|
Announcement Date
|
20/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
543
|
392
|
191
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.8631
x
|
0.5625
x
|
0.2515
x
|
Free Cash Flow
1 |
-
|
248
|
290
|
337
|
ROE (net income / shareholders' equity)
|
-
|
38%
|
33%
|
29.6%
|
ROA (Net income/ Total Assets)
|
-
|
9.81%
|
9.8%
|
10.2%
|
Assets
1 |
-
|
2,864
|
3,004
|
3,132
|
Book Value Per Share
2 |
-
|
4.100
|
5.070
|
6.130
|
Cash Flow per Share
2 |
-
|
2.180
|
2.730
|
-
|
Capex
1 |
-
|
219
|
238
|
241
|
Capex / Sales
|
-
|
7.79%
|
8.07%
|
7.7%
|
Announcement Date
|
29/02/24
|
-
|
-
|
-
|
Last Close Price
42.19
USD Average target price
41.3
USD Spread / Average Target -2.11% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.44% | 2.33B | | -29.15% | 2.32B | | -25.96% | 1.87B | | -16.13% | 958M | | +14.89% | 952M | | -21.39% | 934M | | -7.47% | 699M | | -30.48% | 646M | | +4.91% | 572M |
Testing Laboratories
|